Aller au contenu principal

Clément Cochain

Soumis par com_inem le

Clément Cochain received his PhD from Université Paris 7 in 2011. His doctorate work was performed in the Paris Cardiovascular Research Center under the supervision of J-S Silvestre, and focused on the role of chemokines and their receptors in the initiation and resolution of inflammation during tissue repair after ischemic injury. In 2012, he moved to the lab of Prof. Alma Zernecke (Würzburg, Germany) where he worked on the immune pathogenesis of atherosclerosis, with projects investigating various aspects of the adaptive and innate immune response in vascular inflammation.

Auteurs
Bardin E, Dietrich C, Attailia M, Ferroni A, Jamet A, Lezmi G, Sermet-Gaudelus I, Leite-de-Moraes M

Restored Cytokine-Producing Capacities of Mucosal-Associated Invariant T Cells in Pediatric Cystic Fibrosis Patients Treated with Elexacaftor/Tezacaftor/Ivacaftor

Date revue
Doi
10.1164/rccm.202401-0201LE
Revue
Am J Respir Crit Care Med
Auteurs
Zhu S, Waeckel-Énée E, Oshima M, Moser A, Bessard MA, Gdoura A, Roger K, Mode N, Lipecka J, Yilmaz A, Bertocci B, Diana J, Saintpierre B, Guerrera IC, Scharfmann R, Francesconi S, Mauvais FX, van Endert P

Islet cell stress induced by insulin-degrading enzyme deficiency promotes regeneration and protection from autoimmune diabetes

Date revue
Doi
10.1016/j.isci.2024.109929
Revue
iScience

Michel Sadelain

Soumis par com_inem le

Michel Sadelain is a genetic engineer and cell therapist at Memorial Sloan Kettering Cancer Center (MSKCC) in New York, where he holds the Steve and Barbara Friedman Chair. He is the founding director of the Center for Cell Engineering and a pioneer in T cell engineering and chimeric antigen receptor (CAR) therapy.

Agnès Lehuen

Soumis par com_inem le

Agnes Lehuen is director of the Team “Immunology of diabetes” at Cochin Institute and University Paris City, France. She is cofounder of the Laboratory of Excellence INFLAMEX. 

Auteurs
Bellon N, Bataille P, Bonigen J, Charbit-Henrion F, Dietrich C, Polivka L, Hadj-Rabia S, Leite de Moraes M, Bodemer C

Experience of dupilumab treatment in inherited epidermolysis bullosa: a short series

Date revue
Doi
10.1016/j.jaad.2024.04.037
Revue
J Am Acad Dermatol

Celebration of the ERC Funding in Life Sciences

Soumis par com_inem le

INEM is proud to announce The Celebration of the European Research Council Funding in Life Sciences: From Fundamental Discoveries to Innovative Life-Saving Therapies Symposium, an event co-organised with Association of ERC Grantees, Académine Nationale de Médecine de France and the Ministry of Higher Education and Research, set to showcase the pivotal role of European Research Council (ERC) funding in advancing life sciences research and innovation.

 

 

 

Highlights of the symposium

Matthieu Mahévas - Chaires d’excellence en Biologie Santé de France 2030

Soumis par com_inem le

L'INEM se félicite de la sélection de Matthieu Mahévas parmi les lauréats de l’appel à projets « Chaires d'Excellence en Biologie-Santé » dans le cadre de l'initiative France 2030.

Le dispositif Chaire d’excellence en Biologie-Santé, un programme ambitieux de l'Agence Nationale de la Recherche, a pour objectif d’offrir à des chercheurs de premier plan et de toutes origines des financements conséquents pour mener en France de nouveaux projets d’envergure sur une durée de 5 ans.

S'abonner à